Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
HueDx logo — Accelerating time-to-market for Rapid, Quantitative, Assay-b...

HueDx

Accelerating time-to-market for Rapid, Quantitative, Assay-based (RQA) diagnostic tests

Founded 2017 United States United States 12 employees Seed Total: $3.26M Biotechnology, Health Care +1

General Information

Company Name HueDx
Founded Year 2017
Location United States United States
Employees 12
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with HueDx. To contact HueDx, visit huedx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HueDx compare?

A PDF of HueDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HueDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HueDx

HueDx is a biotechnology and healthcare startup founded in 2017 and headquartered in the United States. The company's slogan, "Accelerating time-to-market for Rapid, Quantitative, Assay-based (RQA) diagnostic tests," reflects its core focus. HueDx offers a Rapid, Quantitative, Assay-based (RQA) test development and launch platform, eliminating the need to develop physical devices and software for launching an RQA product. This innovation makes flagship or complimentary diagnostics accessible to a wider range of companies, including those who may not have previously considered such endeavors, as well as veterans of the process. HueDx's most recent investment was a $655.00K Seed Round investment on 30 July 2020. The details of the investors involved in this round are not presently disclosed. HueDx's strategic positioning within the biotechnology and healthcare industries, along with its innovative approach to accelerating the time-to-market for diagnostic tests, makes it a compelling venture for potential investors to consider.

Business keywords: diagnostic tests, test development, assay-based technology, rapid testing, time-to-market acceleration

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $655.00K -
30 Jul 2020
Series A $1.80M 1
Lehigh Valley Angel Investors
Lehigh Valley Angel Investors
05 Nov 2018
Angel Round $437.50K 1
Full House Asia Holdings
01 Aug 2018
Seed Round $371.25K 1
BioAdvance
BioAdvance
01 Aug 2017
Non Equity Assistance Undisclosed 2
Dreamit Ventures
Dreamit Ventures, Dreamit Healthtech
28 Mar 2017

HueDx Alternatives & Competitors

View All Alternatives
HueDx vs
Premier Medical Corporation Private Limited
Premier Medical Corporation Private Limited India

Commitment to Quality and Care

82 employees
Biotechnology, Hardware
HueDx vs
Domus Diagnostics, Inc
Domus Diagnostics, Inc

Domus is developing affordable and accurate respiratory disease home testing for everyone, everywher...

Grant
5 employees
Biotechnology, Health Care
HueDx vs
In Vitro Diagnostic Solutions (IVDS)
In Vitro Diagnostic Solutions (IVDS) United States

Developing point of care testing solutions that empower patients

15 employees
Biotechnology, Health Care
View all alternatives

FAQ About HueDx

Accelerating time-to-market for Rapid, Quantitative, Assay-based (RQA) diagnostic tests
HueDx was founded in 2017.
HueDx is headquartered in United States.
HueDx operates in Biotechnology, Health Care and Medical Devices. Its work centres on diagnostic tests, test development, assay-based technology and rapid testing.
HueDx has approximately 12 employees.
HueDx has completed 5 funding rounds, raising a total of $3.26M. The latest funding stage is Seed.
Top alternatives and competitors to HueDx include Premier Medical Corporation Private Limited, Domus Diagnostics, Inc, In Vitro Diagnostic Solutions (IVDS), Gaskiya Diagnostics, Aidian. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HueDx and Premier Medical Corporation Private Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HueDx, https://bouncewatch.com/company/huedx, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes